10X GENOMICS DL -00001
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related… Read more
Market Cap & Net Worth: 10X GENOMICS DL -00001 (1KJ)
10X GENOMICS DL -00001 (F:1KJ) has a market capitalization of $1.88 Billion (€1.83 Billion) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #5205 globally and #545 in its home market, demonstrating a -12.18% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying 10X GENOMICS DL -00001's stock price €15.55 by its total outstanding shares 117673382 (117.67 Million).
10X GENOMICS DL -00001 Market Cap History: 2019 to 2026
10X GENOMICS DL -00001's market capitalization history from 2019 to 2026. Data shows change from $8.33 Billion to $1.88 Billion (-17.59% CAGR).
10X GENOMICS DL -00001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how 10X GENOMICS DL -00001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 1KJ by Market Capitalization
Companies near 10X GENOMICS DL -00001 in the global market cap rankings as of March 19, 2026.
Key companies related to 10X GENOMICS DL -00001 by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #731 globally with a market cap of $27.76 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #942 globally with a market cap of $20.52 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2200 globally with a market cap of $6.92 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2264 globally with a market cap of $6.67 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #731 | Veeva Systems Inc Class A | NYSE:VEEV | $27.76 Billion | $184.03 |
| #942 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $20.52 Billion | $144.35 |
| #2200 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.92 Billion | $43.07 |
| #2264 | HealthEquity Inc | NASDAQ:HQY | $6.67 Billion | $79.57 |
10X GENOMICS DL -00001 Historical Marketcap From 2019 to 2026
Between 2019 and today, 10X GENOMICS DL -00001's market cap moved from $8.33 Billion to $ 1.88 Billion, with a yearly change of -17.59%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €1.88 Billion | +15.06% |
| 2025 | €1.63 Billion | +0.41% |
| 2024 | €1.63 Billion | -73.98% |
| 2023 | €6.25 Billion | +52.50% |
| 2022 | €4.10 Billion | -73.31% |
| 2021 | €15.35 Billion | +10.33% |
| 2020 | €13.91 Billion | +66.88% |
| 2019 | €8.33 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of 10X GENOMICS DL -00001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.88 Billion USD |
| MoneyControl | $1.88 Billion USD |
| MarketWatch | $1.88 Billion USD |
| marketcap.company | $1.88 Billion USD |
| Reuters | $1.88 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.